GR950100415A - Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide - Google Patents
Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptideInfo
- Publication number
- GR950100415A GR950100415A GR950100415A GR950100415A GR950100415A GR 950100415 A GR950100415 A GR 950100415A GR 950100415 A GR950100415 A GR 950100415A GR 950100415 A GR950100415 A GR 950100415A GR 950100415 A GR950100415 A GR 950100415A
- Authority
- GR
- Greece
- Prior art keywords
- peptide
- radioactive
- therapeutic agent
- tumor affinity
- agent containing
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 230000002285 radioactive effect Effects 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 title 1
- 229940039227 diagnostic agent Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR95100415 | 1995-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR950100415A true GR950100415A (en) | 1997-07-30 |
Family
ID=10942002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR950100415D GR1002903B (en) | 1995-11-21 | 1995-11-21 | Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
| GR950100415A GR950100415A (en) | 1995-11-21 | 1995-11-21 | Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR950100415D GR1002903B (en) | 1995-11-21 | 1995-11-21 | Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
Country Status (1)
| Country | Link |
|---|---|
| GR (2) | GR1002903B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0329185A2 (en) * | 1988-02-17 | 1989-08-23 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
| WO1992018534A1 (en) * | 1991-04-23 | 1992-10-29 | Antisoma Limited | Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
-
1995
- 1995-11-21 GR GR950100415D patent/GR1002903B/en unknown
- 1995-11-21 GR GR950100415A patent/GR950100415A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0329185A2 (en) * | 1988-02-17 | 1989-08-23 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
| WO1992018534A1 (en) * | 1991-04-23 | 1992-10-29 | Antisoma Limited | Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
Non-Patent Citations (1)
| Title |
|---|
| M.A.SLINKIN E.A.: "Biodistribution of Anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance", NUCL.MED.BIOL., vol. 20, no. 4, pages 443 - 452, XP000362390 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GR1002903B (en) | 1998-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9801390A3 (en) | Radiolabeled peptides for diagnosis and therapy | |
| AU637202B2 (en) | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent | |
| PL305701A1 (en) | Pharmaceutical agent | |
| IL110464A0 (en) | Novel proteins for the diagnosis, imaging, and therapy of human cancer | |
| GB9200949D0 (en) | Diagnostic peptides | |
| EP0831793A4 (en) | Protein particles for therapeutic and diagnostic use | |
| ZA9533B (en) | Pentolifylline therapy | |
| ZA935575B (en) | Therapeutic agent and its use. | |
| IL106037A0 (en) | Therapeutic and diagnostic methods based on neurotrophin-4-expression | |
| EP0612529A3 (en) | Therapeutic agent for NIDDM. | |
| AU4953693A (en) | Antibody/radioisotope conjugate for tumor diagnosis and/or therapy | |
| GB2280036B (en) | Therapy tomograph | |
| ZA965494B (en) | Therapeutic agents. | |
| EP0650372A4 (en) | Compounds for cancer imaging and therapy. | |
| GR950100415A (en) | Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide | |
| GB9319772D0 (en) | Therapeutic agent | |
| ZA959206B (en) | Tumor affinity peptide and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide | |
| GB9510223D0 (en) | Therapeutic agent | |
| IL136210A0 (en) | Reagent for tumor therapy and/or imaging | |
| IL109540A0 (en) | Synthetic peptides and their use in tumor diagnosis and therapy | |
| GB9305228D0 (en) | Metered therapeutic agent application system | |
| GB9406278D0 (en) | Therapeutic agent | |
| ZW1194A1 (en) | Therapeutic agent | |
| IL106658A0 (en) | Cancer diagnosis and treatment | |
| ZA968436B (en) | Peptidyl compounds and their therapeutic use. |